|
Insider Trading: ALLOS THERAPEUTICS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ALLOS THERAPEUTICS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of ALLOS THERAPEUTICS INC since year 2005. Table 2 shows the detailed insider transactions of ALLOS THERAPEUTICS INC since 2005.
The reporting company's ticker symbol is ALTH.
The reporting company's CIK number is 1097264.
The total value of stock buying since 2005 is $123,721,703.
The total value of stock sales is $9,621,263.
The total value of stock exercises is $68,155.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at ALLOS THERAPEUTICS INC (ALTH) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at ALLOS THERAPEUTICS INC (ALTH) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for ALLOS THERAPEUTICS INC (ALTH).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-05 | 13,463,216 | 75,932,535 | 0 | 0 | 0 | 0 |
| 2008-03 | 0 | 0 | 40,500 | 217,398 | 0 | 0 |
| 2008-02 | 793,756 | 4,967,274 | 0 | 0 | 0 | 0 |
| 2008-01 | 984,189 | 7,080,596 | 3,000 | 20,301 | 3,000 | 7,260 |
| 2007-12 | 5,547 | 21,594 | 1,500 | 10,892 | 1,500 | 3,630 |
| 2007-11 | 0 | 0 | 3,000 | 18,846 | 3,000 | 7,260 |
| 2007-10 | 0 | 0 | 3,000 | 17,475 | 3,000 | 7,260 |
| 2007-08 | 0 | 0 | 1,500 | 8,130 | 1,500 | 3,630 |
| 2007-06 | 253 | 460 | 1,571,984 | 9,011,622 | 3,000 | 7,260 |
| 2007-05 | 0 | 0 | 1,500 | 9,133 | 1,500 | 3,630 |
| 2007-03 | 0 | 0 | 23,625 | 152,466 | 0 | 0 |
| 2007-01 | 4,259,022 | 25,554,132 | 0 | 0 | 0 | 0 |
| 2006-12 | 14,680 | 32,861 | 0 | 0 | 0 | 0 |
| 2006-11 | 1,791,139 | 10,107,522 | 0 | 0 | 0 | 0 |
| 2006-06 | 4,582 | 8,333 | 0 | 0 | 0 | 0 |
| 2006-05 | 0 | 0 | 50,000 | 155,000 | 50,000 | 28,225 |
| 2006-04 | 5,000 | 14,700 | 0 | 0 | 0 | 0 |
| 2006-01 | 250 | 572 | 0 | 0 | 0 | 0 |
| 2005-06 | 607 | 1,124 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for ALLOS THERAPEUTICS INC (ALTH)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-05-29 | Leff Jonathan S (Director) | Purchase | 3,500,000 | 5.64 | 19,740,000 |
| 2008-05-29 | Hen Stewart (Director) | Purchase | 3,500,000 | 5.64 | 19,740,000 |
| 2008-05-29 | Warburg Pincus Private Equity Viii L P (Director) | Purchase | 3,500,000 | 5.64 | 19,740,000 |
| 2008-05-22 | Baker Felix (10% Owner) | Purchase | 1,500,000 | 5.64 | 8,459,998 |
| 2008-03-20 | Cagnoni Pablo J (Sr. VP, Chief Medical Officer) | Sale | 6,100 | 5.29 | 32,269 |
| 2008-03-10 | Berns Paul L (Chief Executive Officer) | Sale | 34,400 | 5.38 | 185,129 |
| 2008-02-25 | Baker Felix (10% Owner) | Purchase | 100,000 | 6.00 | 600,000 |
| 2008-02-21 | Baker Felix (10% Owner) | Purchase | 145,000 | 6.05 | 877,247 |
| 2008-02-20 | Baker Felix (10% Owner) | Purchase | 76,380 | 6.50 | 496,421 |
| 2008-02-19 | Baker Felix (10% Owner) | Purchase | 75,713 | 6.75 | 511,326 |
| 2008-01-23 | Baker Felix (10% Owner) | Purchase | 20,677 | 6.95 | 143,734 |
| 2008-01-22 | Baker Felix (10% Owner) | Purchase | 747 | 6.92 | 5,164 |
| 2008-01-18 | Baker Felix (10% Owner) | Purchase | 12,424 | 7.18 | 89,257 |
| 2008-01-15 | Baker Felix (10% Owner) | Purchase | 26,000 | 7.50 | 194,999 |
| 2008-01-14 | Baker Felix (10% Owner) | Purchase | 130,000 | 7.41 | 963,921 |
| 2008-01-11 | Baker Felix (10% Owner) | Purchase | 55,000 | 7.47 | 411,018 |
| 2008-01-10 | Baker Felix (10% Owner) | Purchase | 115,800 | 7.47 | 864,931 |
| 2008-01-09 | Baker Felix (10% Owner) | Purchase | 62,400 | 6.96 | 434,314 |
| 2008-01-08 | Baker Felix (10% Owner) | Purchase | 200,000 | 7.21 | 1,442,338 |
| 2008-01-07 | Johnson Douglas G (VP of Manufacturing) | Sale | 1,500 | 7.24 | 10,860 |
| 2008-01-07 | Johnson Douglas G (VP of Manufacturing) | Option Exercise | 1,500 | 2.42 | 3,630 |
| 2008-01-07 | Baker Felix (10% Owner) | Purchase | 101,444 | 6.53 | 662,389 |
| 2008-01-02 | Johnson Douglas G (VP of Manufacturing) | Sale | 1,500 | 6.29 | 9,441 |
| 2008-01-02 | Johnson Douglas G (VP of Manufacturing) | Option Exercise | 1,500 | 2.42 | 3,630 |
| 2007-12-31 | Johnson Douglas G (VP of Manufacturing) | Purchase | 547 | 3.89 | 2,129 |
| 2007-12-31 | Berns Paul L (Chief Executive Officer) | Purchase | 5,000 | 3.89 | 19,465 |
| 2007-12-03 | Johnson Douglas G (VP of Manufacturing) | Sale | 1,500 | 7.26 | 10,892 |
| 2007-12-03 | Johnson Douglas G (VP of Manufacturing) | Option Exercise | 1,500 | 2.42 | 3,630 |
| 2007-11-28 | Johnson Douglas G (VP of Manufacturing) | Sale | 1,500 | 6.72 | 10,080 |
| 2007-11-28 | Johnson Douglas G (VP of Manufacturing) | Option Exercise | 1,500 | 2.42 | 3,630 |
| 2007-11-01 | Johnson Douglas G (VP of Manufacturing) | Sale | 1,500 | 5.84 | 8,766 |
| 2007-11-01 | Johnson Douglas G (VP of Manufacturing) | Option Exercise | 1,500 | 2.42 | 3,630 |
| 2007-10-15 | Johnson Douglas G (VP of Manufacturing) | Sale | 1,500 | 6.23 | 9,345 |
| 2007-10-15 | Johnson Douglas G (VP of Manufacturing) | Option Exercise | 1,500 | 2.42 | 3,630 |
| 2007-10-05 | Johnson Douglas G (VP of Manufacturing) | Sale | 1,500 | 5.42 | 8,130 |
| 2007-10-05 | Johnson Douglas G (VP of Manufacturing) | Option Exercise | 1,500 | 2.42 | 3,630 |
| 2007-08-10 | Johnson Douglas G (VP of Manufacturing) | Sale | 1,500 | 5.42 | 8,130 |
| 2007-08-10 | Johnson Douglas G (VP of Manufacturing) | Option Exercise | 1,500 | 2.42 | 3,630 |
| 2007-06-29 | Johnson Douglas G (VP of Manufacturing) | Purchase | 253 | 1.82 | 460 |
| 2007-06-21 | Baker Felix (10% Owner) | Sale | 89,700 | 5.55 | 497,950 |
| 2007-06-19 | Johnson Douglas G (VP of Manufacturing) | Sale | 1,500 | 6.63 | 9,945 |
| 2007-06-19 | Johnson Douglas G (VP of Manufacturing) | Option Exercise | 1,500 | 2.42 | 3,630 |
| 2007-06-19 | Baker Felix (10% Owner) | Sale | 1,098,313 | 5.75 | 6,312,331 |
| 2007-06-06 | Caruso James V (Chief Commercial Officer) | Sale | 10,000 | 5.62 | 56,150 |
| 2007-06-01 | Johnson Douglas G (VP of Manufacturing) | Sale | 1,500 | 5.77 | 8,658 |
| 2007-06-01 | Johnson Douglas G (VP of Manufacturing) | Option Exercise | 1,500 | 2.42 | 3,630 |
| 2007-05-04 | Johnson Douglas G (VP of Manufacturing) | Sale | 1,500 | 6.09 | 9,133 |
| 2007-05-04 | Johnson Douglas G (VP of Manufacturing) | Option Exercise | 1,500 | 2.42 | 3,630 |
| 2007-03-12 | Berns Paul L (Chief Executive Officer) | Sale | 23,625 | 6.45 | 152,466 |
| 2007-01-29 | Baker Felix (10% Owner) | Purchase | 3,300,000 | 6.00 | 19,800,000 |
| 2006-12-29 | Malek Eric (VP of Corporate Development) | Purchase | 1,223 | 1.82 | 2,224 |
| 2006-12-29 | Saunders Michael E (VP, Clinical Development) | Purchase | 2,500 | 1.82 | 4,547 |
| 2006-12-29 | Graboyes Marc H (VP, General Counsel) | Purchase | 2,500 | 1.82 | 4,547 |
| 2006-12-29 | Johnson Douglas G (VP of Manufacturing) | Purchase | 2,247 | 1.82 | 4,087 |
| 2006-12-29 | Herzig Markus F (VP Regulatory Affairs) | Purchase | 1,210 | 1.82 | 2,200 |
| 2006-12-29 | Caruso James V (Chief Commercial Officer) | Purchase | 2,500 | 3.05 | 7,628 |
| 2006-12-29 | Berns Paul L (Chief Executive Officer) | Purchase | 2,500 | 3.05 | 7,628 |
| 2006-11-28 | Baker Felix (10% Owner) | Purchase | 300,000 | 5.50 | 1,649,999 |
| 2006-11-17 | Baker Felix (10% Owner) | Purchase | 115,000 | 5.75 | 660,811 |
| 2006-11-16 | Baker Felix (10% Owner) | Purchase | 155,000 | 5.80 | 899,448 |
| 2006-11-15 | Baker Felix (10% Owner) | Purchase | 460,000 | 5.66 | 2,602,219 |
| 2006-06-30 | Malek Eric (VP of Corporate Development) | Purchase | 1,209 | 1.82 | 2,199 |
| 2006-06-30 | Graboyes Marc H (VP, General Counsel) | Purchase | 1,888 | 1.82 | 3,434 |
| 2006-06-30 | Johnson Douglas G (VP of Manufacturing) | Purchase | 195 | 1.82 | 354 |
| 2006-06-30 | Herzig Markus F (VP Regulatory Affairs) | Purchase | 1,290 | 1.82 | 2,346 |
| 2006-05-26 | Hart Michael E | Sale | 50,000 | 3.10 | 155,000 |
| 2006-05-26 | Hart Michael E | Option Exercise | 50,000 | .56 | 28,225 |
| 2006-04-13 | Berns Paul L (Chief Executive Officer) | Purchase | 5,000 | 2.94 | 14,700 |
| 2006-01-17 | Herzig Markus F (VP Regulatory Affair) | Purchase | 250 | 2.29 | 572 |
| 2005-06-30 | Clark David C (Controller) | Purchase | 272 | 1.85 | 504 |
| 2005-06-30 | Johnson Douglas G (VP of Manufacturing) | Purchase | 335 | 1.85 | 620 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of ALLOS THERAPEUTICS INC (symbol ALTH,
CIK number 1097264) see
the Securities and Exchange Commission (SEC) website.
|
|
